Topics

The European Investment Bank loans Polish biotech $33m for growth

12:34 EDT 28 Oct 2019 | Manufacturing Chemist

Blood cancer-focused Mabion will use the financing for its R&D programme, conducting clinical trials, as well as expanding its manufacturing capacities

Original Article: The European Investment Bank loans Polish biotech $33m for growth

NEXT ARTICLE

More From BioPortfolio on "The European Investment Bank loans Polish biotech $33m for growth"

Quick Search

Relevant Topics

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Clinical Approvals
Clinical trials are a set of procedures in medical research conducted to allow safety (or more specifically, information about adverse drug reactions and adverse effects of other treatments) and efficacy data to be collected for health interventions (e.g...